Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 83904 refers to a specific molecular diagnostic procedure that focuses on the identification of mutations through DNA sequencing. This process involves analyzing a tissue sample to detect any alterations in the DNA sequence that may be indicative of a disease or disorder. The term "mutation identification by sequencing" signifies that the procedure is designed to pinpoint specific changes in the genetic material, which can be crucial for diagnosing various medical conditions. The phrase "single segment, each segment" indicates that the analysis is performed on one segment of DNA at a time, allowing for a detailed examination of specific areas of interest within the genetic code. This targeted approach is essential for understanding the genetic underpinnings of certain diseases, enabling healthcare providers to make informed decisions regarding patient care and treatment options.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 83904 is indicated for various clinical scenarios where mutation identification is necessary. These indications may include, but are not limited to, the following:
The procedure for CPT® Code 83904 involves several key steps to ensure accurate mutation identification through DNA sequencing. Each step is critical for the integrity and reliability of the results.
Post-procedure care for patients undergoing testing with CPT® Code 83904 typically involves monitoring for any immediate complications related to the tissue sample collection, especially if a biopsy was performed. Patients may be advised on how to care for the biopsy site, including keeping it clean and dry. Additionally, healthcare providers will discuss the timeline for receiving results, which can vary based on the complexity of the analysis. Once results are available, follow-up appointments may be scheduled to discuss the findings and any necessary next steps in diagnosis or treatment based on the identified mutations.
| Short Descr | MOLECULE MUTATION IDENTIFY | Medium Descr | MOLECULE MUTATION IDENTIFY | Long Descr | Molecular diagnostics; mutation identification by sequencing, single segment, each segment | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.